Clofabosin: Difference between revisions
mNo edit summary |
mNo edit summary |
||
| Line 389: | Line 389: | ||
Yes-no questions are formed by adding the question particle ''pegol'' to the subjunctive: ''Zenazumab pegol?'' (Did he go?). However, colloquial speech often shortens this to ''-mapel'' or even ''-mpel''. "What" questions do ''not'' use this ending: ''cesin gliserotin(avir)?'' = what language is this? | Yes-no questions are formed by adding the question particle ''pegol'' to the subjunctive: ''Zenazumab pegol?'' (Did he go?). However, colloquial speech often shortens this to ''-mapel'' or even ''-mpel''. "What" questions do ''not'' use this ending: ''cesin gliserotin(avir)?'' = what language is this? | ||
The negative uses the ''-fo-'' marker after the verb stem: ''sabafovir'' 'he does not write'. For subjunctive forms, the negative marker is ''-tu | The negative uses the ''-fo-'' marker after the verb stem: ''sabafovir'' 'he does not write'. For irrealis forms (e.g. subjunctive, conditional, and optative forms), the negative marker is ''-tu-'': ''Sabatumab!'', ''Sabatumumab!'' or ''Sabatumomab!'' means 'Don't write!' | ||
*'can' (ability) uses ''-tecan'' (inflected as if it were ''-tecavir''; the attributive is ''-taxel'') | *'can' (ability) uses ''-tecan'' (inflected as if it were ''-tecavir''; the attributive is ''-taxel'') | ||